The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns

被引：36

作者：

Cuende, Natividad ^{[1
]}

Boniface, Christelle ^{[2
]}

Bravery, Christopher ^{[3
]}

Forte, Miguel ^{[2
]}

Giordano, Rosaria ^{[4
]}

Hildebrandt, Martin ^{[5
]}

Izeta, Ander ^{[6
]}

Dominici, Massimo ^{[7
]}

机构：

[1] Junta Andalucia, Serv Andaluz Salud, Andalusian Initiat Adv Therapies, Seville, Spain

[2] TxCell SA, Valbonne, Sophia Antipoli, France

[3] Consulting Adv Biol Ltd, London, England

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[5] Tech Univ Munich, TUMCells Interdisciplinary Ctr Cellular Therapie, D-80290 Munich, Germany

[6] Hosp Univ Donostia, Inst Biodonostia, Tissue Engn Lab, San Sebastian, Spain

[7] Univ Hosp Modena & Reggio Emilia, Lab Cell Biol & Adv Canc Therapies, Modena, Italy

来源：

CYTOTHERAPY | 2014年 / 16卷 / 12期

关键词：

MARROW MONONUCLEAR-CELLS;

D O I：

10.1016/j.jcyt.2014.08.007

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

[No abstract available]

引用

页码：1597 / 1600

页数：4

共 10 条

[1]

[Anonymous], 2013, REGEN MED, V8, P121, DOI [10.2217/RME.12.116, 10.2217/rme.12.116]

[2]

[Anonymous], GUID UKS ARR HOSP EX

[3]

[Anonymous], 2001, Official Journal of the European Communities, VL311, P67

[4]

[Anonymous], 2007, Official Journal of the European Union, V10-12-2007, P121

[5] When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes [J].

Cuende, Natividad ;

Herrera, Concha ;

Keating, Armand .

HAEMATOLOGICA, 2013, 98 (03) :323-324

[6] Concise Review: Bone Marrow Mononuclear Cells for the Treatment of Ischemic Syndromes: Medicinal Product or Cell Transplantation? [J].

Cuende, Natividad ;

Rico, Laura ;

Herrera, Concha .

STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (05) :403-408

[7]

Erben RG, 2014, TISSUE ENG A

[8]

EU, 2009, OFFICIAL J EUROPEAN, V242, P3

[9]

European Union, 2004, Official Journal of the European Communities, VL 136, P1

[10] Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive [J].

Maciulaitis, Romaldas ;

D'Apote, Lucia ;

Buchanan, Andrew ;

Pioppo, Laura ;

Schneider, Christian K. .

MOLECULAR THERAPY, 2012, 20 (03) :479-482

← 1 →